Remedicalizing Cannabis: Science, Industry, and Drug Policy

✍ Scribed by Suzanne Taylor

• Publisher: McGill-Queen's University Press
• Year: 2022
• Tongue: English
• Leaves: 305
• Series: Intoxicating Histories
• Category: Library

✦ Synopsis

A contemporary history of the remedicalization of cannabis and the shifting boundaries between licit and illicit drugs.

Remedicalizing Cannabis discovers the historical ins and outs of cannabis as a botanical product with medical applications. Addressing questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it reveals how we have arrived at the current classification of cannabis as a medical product.

✦ Table of Contents

Cover
REMEDICALIZING CANNABIS
Title
Copyright
Contents
Figures
Acknowledgements
Abbreviations
Introduction
1 Understanding Cannabis: Pharmacology, Laboratory Research, and Drug Control, 1964–82
2 Cannabis in the Clinic: Clinical Pharmacology and the Therapeutic Applications of Cannabis, 1973–82
3 Evidence-Based Policy? The Development of Expert Committees, 1972–82
4 Industrializing Cannabis: The Pharmaceutical Industry and the Remedicalization of Cannabis, 1973–2001
5 Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis, 1973–2001
6 Establishing Therapeutic Cannabis: The Role of Expert Advice, 1997–2001
7 From Anecdotal to Evidence-Based Medicine: The Role of Clinical Trials, 1995–2005
8 Accessing Cannabis-Based Medicinal Products (CBMPS), 2009–21
Conclusion
Notes
Bibliography
Index